Page 8 March 16, 2017 Purrrfect Companions Lilo Stitch Kitten Rescue is honored to be an official charity of the 2017 Skechers Performance Los Angeles Marathon for the sixth year in a row! Join one of our three teams and help us reach our fundraising goal of $100,000! Not up for a full marathon? Then help us save homeless animals by joining “Team Kitten Rescue” in the 5K of the Los Angeles Marathon on Sunday, March 19 (a link to more info is available on the home page of our website…www.kittenrescue.org). Take a look at this week’s featured kitties (with many more waiting for you on our website). All of these cats and kittens are waiting to share their love with their purr-fect someone who will give them a new forever home. Lilo is a gorgeous, playful lady with a striking white heart on her jet-black chest. She’s loving as can be and is especially dedicated to her brother Stitch, with whom she would love to find a home. When she can’t find him or a human companion, she runs around the house calling for someone until she finds her brother or a lap on which to sit. She is litter-trained and ready to go home with you! For you admirers of handsome, gray boy kitties, you’ve found your man. Stitch is an absolute purr machine who is curious, gentle, loves cuddles and is just an all-around sweetheart. He’s a vocal guy--not in the yowling sense--but he loves to talk to you about what he’s doing! He is especially fond of his sister Lilo and would love to find a home with her. He has spent some time around small children and is so great with them! He is also litter-trained and is waiting for a home with you. Gypsy is a fun, playful, adventurous girl with an unusual, adorable meow. She spends her days playing with her cat toys, climbing her cat tree and roaming around her foster home looking for her next adventure. She is a very sweet kitty that loves cuddle sessions. Gypsy is very social and doesn’t like to be left home alone, so ideally she would be adopted into a home with another cat or adopted together with another Kitten Rescue kitten. She is young enough to adapt to a household with dogs, but needs a kitty companion too. binge-watching Netflix. Phoenix likes to spend his days wrestling with his foster siblings and playing with his cat toys. On his breaks, he loves to bask in the sun atop the cat tree or stretch out on the bed. Phoenix is gentle and loving and gets along with the other kitties in his foster home. This handsome young guy has a long, beautiful, fluffy tail like a squirrel and big, soulful, puppy dog eyes. Penelope is a sweet, delicate and elegant kitty with a huge personality. She has long, Ginger is a beautiful girl. She is very affectionate and loving once she warms up and gets to know her people. She is good with dogs that don’t chase and she warms up to other cats. Ginger loves to be petted and brushed, and will crawl on a person to whom she can give kisses (light licks). She has been completely vetted (including recent blood work and a full dental). She is easygoing, well-behaved and flexible. Ginger would do well in almost any safe and loving home, but could especially be good as a wonderful lap buddy to an older person. Ragnar is pure joy. It must be good to be Ragnar because everything is just so much fun for him. He is a super sweet, cuddly, affectionate goofball with just a hint of cerebellar hypoplasia (his reward for surviving pan leukopenia). It’s not enough to cause any real impairment, but just enough that he has a slight head bobble and is clumsy in a very endearing way. It certainly doesn’t slow him down, as he gets the zooms just like any other kitty his age. Ragnar has been brought up in a home with several cats and kittens as well as dogs. He’s more a fan of his feline compadres and would be a great companion for anyone who likes to cuddle and play. Ragnar will let you pick him up and carry him around like a baby, and will bring a smile to your face with his sweet and clumsy shenanigans. Mable was discovered in a very pregnant state on a cold, rainy night in December. She was looking for a warm, dry place to deliver her kittens. We brought her inside, and the next morning she delivered two beautiful babies. Mable has been a wonderful mommy, and successfully weaned and raised two adorable kittens. She is a gorgeous, sweet and affectionate kitty who loves to sleep and cuddle with people. Still a young kitty herself, she can be very curious and playful. She was temporarily named “Mable” because she looks like she is wearing Maybelline eyeliner!. Phoenix was found living on the street as a kitten and was so happy to be rescued. He is a very friendly boy who loves affection. He is the perfect companion to cuddle up with while Ragnar soft hair and a fluffy tail that is to die for! She also has great markings. Did you notice her white mustache? Penelope was rescued along with her mom and siblings and has been socialized with other cats and dogs. She equally enjoys playing with her sibling or her best friend, a Chihuahua pup. With her “good morning kisses,” you will never have a bad day again, guaranteed! These kitties are available for adoption through Kitten Rescue, one of the largest cat rescue groups in Southern California. All our kitties are spayed/neutered, microchipped, tested for FeLV and FIV, dewormed and current on their vaccinations. For additional information and to see these or our other kittens and cats, please check our website www.kittenrescue.org or email us at mail@kittenrescue.org. Your tax-deductible donations for the rescue and care of our cats and kittens can be made through our website or by sending a check payable to Kitten Rescue, 914 Westwood Boulevard, #583, Los Angeles, CA 90024. On Saturdays, we have adoptions from noon to 3:30 p.m. in Westchester at 8655 Lincoln Boulevard just south of Manchester Avenue, and also in Mar Vista at 3860 Centinela Avenue just south of Venice Boulevard. Our website lists additional adoption sites and directions to each location. • Mable Phoenix Gypsy Ginger Price Hikes from front page faith-based investors, many of them members of an interfaith push for corporate responsibility, doesn’t appear to be finished. The SEC staff’s decision not to recommend any enforcement action against drug makers for ignoring these shareholder requests only covers this year, so they could be back. “The first shareholder proposal on drug pricing that I’m aware of was successful in the 1990s,” Neuhauser said. “There have been successful ones since. I think the problem this year was more the way it worded than the basic notion.” Shareholders in three 2015 cases overcame a drug maker’s resistance to producing its pricing data, according to Neuhauser. In each case, the companies argued like Amgen that investors were trying to micromanage the business operations, yet SEC staff rejected the argument Neuhauser presented in January in writing. The former law school professor pointed to other SEC’s staff opinions regarding drug companies and price-setting. “This is not too intricate a matter for shareholders to understand. Note that it is the rate of increase that is being requested, not the actual prices charged. Indeed, the proposal ‘micromanages’ significantly less than the proposals that were deemed not to micromanage in Celgene Corp. (March 9, 2015), Vertex Pharmaceuticals Inc. (February 25, 2015) and Gilead Sciences, Inc. (February 23, 2015),” he wrote. Calls to Amgen representatives for comment about the pricing of its leading drug therapies went unreturned as of late last week. The company’s website did not mention the SEC lawyer’s favorable ruling. Amgen had product sales of $21.9 billion last year, and total revenues increased six percent, according to 2016 financials. Drug sales grew six percent in 2016 over the previous year, led by a 49 percent increase in sales of Blincyto for leukemia patients. The company’s other big gainers for the year included Kyprolis for treatment of myeloma–up 35 percent–and bone-density-building Prolia, which was up 25 percent in annual sales. The top-10 sellers for Amgen, which the shareholder group targeted in its proposal, generated $16.6 billion for the biotech firm last year. Only a dozen or so drug companies outsell this Southern California success story. The company can choose to address at its annual shareholder meeting the drug-pricing issue and the risks from the current political debate over healthcare costs in the nation’s and state capitals, but for now the federal government watchdog over publicly traded companies won’t force pharmaceutical makers to say anything. This ruling is corporate America’s version of the Miranda rule. The SEC decided a drug maker has the right to remain silent, even when it’s the investor-owners of the company asking the questions. •
Lawndale_FB_031617_FNL_lorez
To see the actual publication please follow the link above